Scientific research

Conventional laboratories conduct immunoassays using a technique known as enzyme linked immunosorbent assays (ELISA), which remains dependent on 12 manual steps. Despite some advancement in detection methods, multiplexed immunoassays still necessitate the same labor intensive steps proposed forty years ago, causing large turnaround times and significant human error. The Medical Acute Immune Diagnostics (MedAID) system was designed to reduce the number of steps in order to provide a platform for faster and more accurate multiplexed immunoassays.

This is achieved through the use of a proprietary immune complex, which allows label-based detection in a single step. Multiple groups have developed label-free immunoassays capable of detection following a single binding step. Despite drastically increased speed, prohibitively high cost and low sensitivity have prevented commercial use. Others have developed all-in-one assays which maintain cost and sensitivity, but provide only modest time savings. Unlike competitor technologies, MedAID allows single step immunoassays to be performed with nearly any detection method, providing a simple and inexpensive means of increasing assay speed and sensitivity.